Yoo S E, Kim S K, Lee S H, Kim N J, Lee D W
Bio-Organic Science Division, Korea Research Institute of Chemical Technology, Taejon, South Korea.
Bioorg Med Chem. 2000 Sep;8(9):2311-6. doi: 10.1016/s0968-0896(00)00164-4.
As a continuing effort to establish the structure and activity relationship in a benzofuran type of angiotensin II antagonist, we synthesized various regioisomers and performed a series of QSAR analyses. The conformational analyses of target isomers were carried out using molecular mechanics and fine-tuned using the information from the NMR NOE experiment. The conformations of compounds with a good binding activity are quite similar to that of DuP753, a prototype of AII antagonist, suggesting that these compounds also bind to the same site of AII receptor. We then studied the compounds with a varied length of the hydroxyl group bearing side chain to find out the optimum distance between the hydroxyl group and the imidazole ring. The CoMFA with these compounds gave acceptable statistical measures (cross-validated r2 and conventional r2 to be 0.881 and 0.974, respectively) and the map was well consistent with the previously proposed pharmacophore.
作为建立苯并呋喃型血管紧张素II拮抗剂结构与活性关系的持续努力,我们合成了各种区域异构体并进行了一系列定量构效关系(QSAR)分析。使用分子力学对目标异构体进行构象分析,并根据核磁共振(NMR)核Overhauser效应(NOE)实验的信息进行微调。具有良好结合活性的化合物的构象与血管紧张素II拮抗剂原型DuP753的构象非常相似,这表明这些化合物也与血管紧张素II受体的同一部位结合。然后,我们研究了带有不同长度羟基侧链的化合物,以找出羟基与咪唑环之间的最佳距离。对这些化合物进行的比较分子场分析(CoMFA)给出了可接受的统计指标(交叉验证的r2和常规r2分别为0.881和0.974),并且图谱与先前提出的药效团高度一致。